The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
暂无分享,去创建一个
R. Weimann | A. Zimmermann | D. Stroka | F. Stickel | V. Banz | E. Patsenker | L. Wilkens | A. Keogh | S. Eisele | C. Österreicher | C. Osterreicher
[1] B. Teh,et al. Cholangiocarcinoma , 2021, Nature Reviews Disease Primers.
[2] D. Schuppan,et al. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. , 2008, Gastroenterology.
[3] H. Friess,et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.
[4] M. Pekalski,et al. Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease , 2008, Laboratory Investigation.
[5] A. Gown,et al. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. , 2009, Archives of pathology & laboratory medicine.
[6] P. Weinreb,et al. Role of αvβ6 integrin in acute biliary fibrosis , 2007 .
[7] D. Schuppan,et al. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. , 2007, Journal of hepatology.
[8] P. Weinreb,et al. Role of alphavbeta6 integrin in acute biliary fibrosis. , 2007, Hepatology.
[9] G. Gores,et al. Cholangiocarcinoma: modern advances in understanding a deadly old disease. , 2006, Journal of hepatology.
[10] Raghu Kalluri,et al. The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.
[11] J. Haier,et al. Integrins in cancer treatment. , 2006, Current cancer drug targets.
[12] Yury Popov,et al. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. , 2005, Journal of hepatology.
[13] C. Moskaluk,et al. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. , 2005, Human pathology.
[14] P. Oettgen,et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. , 2005, The Journal of clinical investigation.
[15] S. Goodman,et al. Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro , 2004 .
[16] D. Stolz,et al. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT , 2004, Transplantation.
[17] J. Bavaria,et al. Integrin expression in non-small cell carcinoma of the lung , 1995, Cancer and Metastasis Reviews.
[18] H. Larjava,et al. Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds. , 2004, The American journal of pathology.
[19] S. Goodman,et al. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. , 2004, Histopathology.
[20] M. Makuuchi,et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. , 2003, Japanese journal of clinical oncology.
[21] T. Minamoto,et al. Expression of αv Integrin Family in Gastric Carcinomas: Increased αvβ6 is Associated with Lymph Node Metastasis , 2003 .
[22] T. Minamoto,et al. Expression of alphav integrin family in gastric carcinomas: increased alphavbeta6 is associated with lymph node metastasis. , 2003, Pathology, research and practice.
[23] H. Thomas,et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.
[24] G. Rice,et al. αvβ6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer , 2002 .
[25] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[26] R. Jordan,et al. Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas , 2002 .
[27] G. Rice,et al. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] R. Jordan,et al. Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. , 2002, Oral oncology.
[29] R. Pytela,et al. Role of the αvβ6 Integrin in Human Oral Squamous Cell Carcinoma Growth in Vivo and in Vitro , 2001 .
[30] R. Pytela,et al. Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. , 2001, Biochemical and biophysical research communications.
[31] B. le Bail,et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. , 2000, The American journal of surgical pathology.
[32] G. Mizejewski,et al. Role of integrins in cancer: survey of expression patterns. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[33] Lily T Ma,et al. Combined hepatocellular‐cholangiocarcinoma: A clinicopathological study , 1998, Journal of gastroenterology and hepatology.
[34] J. Lau,et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. , 1996, The American journal of pathology.
[35] T. Kudo,et al. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. , 1995, The Tohoku journal of experimental medicine.
[36] K. Aldape,et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. , 1995, Journal of cell science.
[37] C. Van Waes. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing , 1995, Head & neck.
[38] R. Joplin. Isolation and culture of biliary epithelial cells. , 1994, Gut.
[39] D. Sheppard,et al. Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[40] V. Desmet,et al. Integrins as differential cell lineage markers of primary liver tumors. , 1993, The American journal of pathology.
[41] G. Stamp,et al. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors. , 1992, Human pathology.
[42] Y. Kondō,et al. Well‐Differentiated Cholangiocarcinoma: Diagnostic Significance of Morphologic and Immunohistochemical Parameters , 1989, The American journal of surgical pathology.
[43] S. Sell,et al. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. , 1989, The American journal of pathology.
[44] T. Morohoshi,et al. The significance of alpha‐fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours , 1989, Histopathology.
[45] S. Thung,et al. Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma. , 1989, Archives of pathology & laboratory medicine.
[46] M. Nadji,et al. Histologic markers in primary and metastatic tumors of the liver , 1988, Cancer.